Novo Nordisk Warns About Insulin Pen Cartridge-Holder Problems
Executive Summary
New insulin-cartridge holders are being sent to users worldwide after the use of cleaning chemicals was linked to cracked holders in specific batches of NovoPen Echo and NovoPen 5, and increased ADR risks.
You may also be interested in...
Novo Nordisk CEO Puts Pricing On The Line
Lars Fruergaard Jørgensen, Novo Nordisk's CEO, says the group's pledge on price transparency, goals for improved outcomes and experimental use of digital health are commercially linked.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.